The prognostic model constructed in this study incorporated 15 tumor-cell-specific genes (SRSF7, NQO1, APCS, NUPR1, SCARB1, DAB2, ANG, PPP2R1B, C1S, SERPINE1, GADD45G, ITIH1, PDK4, HSP90AA1, SAT1) associated with progression and treatment resistance. This evidence concerns the gene NUPR1 and neoplasm.